Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Illumina Inc. stock faces renewed scrutiny amid Grail divestiture delays and biotech sector headwind
Illumina Inc. is encountering renewed scrutiny due to persistent delays in its Grail divestiture and broader biotech sector headwinds. Regulatory hurdles, particularly in the EU and US, are extending the timeline for spinning off Grail, negatively impacting margins and investor confidence. Despite these challenges, the company is pivoting towards high-growth areas like spatial transcriptomics and AI-powered data analysis, which are seen as long-term catalysts by investors, especially in the DACH region.